期刊文献+

DNA甲基转移酶在肝细胞癌中的表达及其临床意义 被引量:1

Expression and clinical significance of DNA methyltransferases in hepatocellular carcinoma
原文传递
导出
摘要 目的探讨DNA甲基转移酶1(DNMTl)、3a(DNMT3a)和3b(DNMT3b)在肝细胞癌(HCC)中的表达及其意义。方法应用免疫组织化学检测47例HCC癌组织、42例HCC癌旁肝组织及12例正常肝组织中DNMTl、DNMT3a和DNMT3b的表达情况,分析三者与临床病理特征的关系。结果DNMTl、DNMT3a和DNMT3b在HCC中阳性表达率分别为80.9%、68.1%和78.7%,在癌旁组织内分别为50.0%、52.4%和57.1%,均明显高于正常肝组织内的阳性表达(16.7%、16.7%和25.0%)。而且DNMTl、DNMT3a和DNMT3b与HCC的病理分化类型及乙肝表面抗原阳性显著相关(P〈0.05)。结论DNMTl、DNMT3a和DNMT3b的异常表达与HcC的发生发展有紧密的关系。 Objective To investigate the expression of DNA methyltransferase 1, 3a, 3b (DN- MT1, DNMT3a, DNMT3b) in human hepatocellular carcinoma (HCC) and to determine their clinical significance. Methods The expression of DNMT1,3a, 3b proteins was detected in 47 HCC tumor specimens and 42 HCC paracarcinoma liver tissues by immunohistoehemistry. 12 normal liver tissues were used as control. The results and clinicopathological parameters were analyzed. Results The pos- itive expression rates of DNMT1, 3a and 3b in HCC tissues were 80.9%, 68.1% and 78.7% respec- tively. The positive expression rates of DNMT1, DNMT3a and DNMT3b in paracareinoma tissues were 50.0%, 52.4% and 57. 1% respectively. The expression rates of DNMT1, 3a and 3b in both HCC tissues and paracarcinoma tissues were significantly higher than normal liver tissues. The ex- pression of DNMT1, DNMT3a, DNMT3b was correlated with tumor differentiation (P〈0.05) and hepatitis B surface antigen (HBsAg) positivity. Conclusions DNMT1, 3a and 3b play important roles in carcinogenesis and development of HCC.
作者 沈苑 顾栋桦
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2012年第11期837-840,共4页 Chinese Journal of Hepatobiliary Surgery
关键词 肝细胞癌 DNA甲基转移酶 Hepatocellular carcinoma DNA methyltransferase
  • 相关文献

参考文献8

二级参考文献84

  • 1Shanshan Pang,Yingying Le.Role of Resistin in Inflammation and Inflammation-Related Diseases[J].Cellular & Molecular Immunology,2006,3(1):29-34. 被引量:25
  • 2荣愈平,沈世强,陈亮,汪栋宇.肝细胞癌组织RASSFIA基因的表达及临床意义[J].中华肝胆外科杂志,2007,13(1):65-66. 被引量:1
  • 3Dannenberg LO,Edenberg HJ.Epigenetics of gene expression in human hepatoma cells:expression profiling the response to inhibition of DNA methylation and histone deacetylation.BMC Genomics,2006,7:181-192.
  • 4Luedi PP,Dietrich FS,Weidman JR,Bosko JM,Jirtle RL,Hartemink AJ.Computational of novel human imprinted genes and experimental identification.Genome Res,2007,17(12):1723-1730.
  • 5Srivastava M,Hsieh S,Grinberg A,Williams-Simons L,Huang SP,Pfeifer K.H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19.Genes Dev,2000,14(10):1186-1195.
  • 6Trasler JM.Gamete imprinting:setting epigenetie patterns for the next generation.Reprod Fertil Dev,2006,18(1-2):63-69.
  • 7Kaneda M,Okano M,Hata K,Sado T,Tsujimoto N,Li E,Sasaki H.Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting.Nature,2004,429(6994):900-903.
  • 8Kato Y,Kaneda M,Hata K,Kumaki K,Hisano M,Kohara Y,Okano M,Li E,Nozaki M,Sasaki H.Role of the Dnmt3 family in de novo methylation of imprinted and repetitive sequences during male germ cell development in the mouse.Hum Mol Genet,2007,16(19):2272-2280.
  • 9Yokomine T,Hata K,Tsudzuki M,Sasaki H.Evolution of the vertebrate Dnmt3 gene family:a possible link between existence of Dnmt3L and genomic imprinting.Cytogenet Genome Res,2006,113(1-4):75-80.
  • 10Suetake I,Morimoto Y,Fuchikami T,Abe K,Tajima S.Stimulation effect of Dnmt3L on the DNA methylation activity of Dnmt3a2.J Biochem,2006,140(4):553-559.

共引文献42

同被引文献48

  • 1Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer,and cancer stem cells[J]. Nature, 2001,414(6859):105-111.
  • 2Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J]. Nat Med, 1997,3(7):730-737.
  • 3Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci USA, 2003,100(7):3983-3988.
  • 4Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells[J]. Nature, 2004,432(7015):396-401.
  • 5Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells[J]. Cancer Res, 2005,65(23):10946-10951.
  • 6Haraguchi N, Utsunomiya T, Inoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system[J]. Stem Cells, 2006,24(3):506-513.
  • 7Ma S, Lee TK, Zheng BJ, et al. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway[J]. Oncogene, 2008,27(12):1749-1758.
  • 8Zhu Z, Hao X, Yan M, et al. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma[J]. Int J Cancer, 2010,126(9):2067-2078.
  • 9Yamashita T, Ji J, Budhu A, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features[J]. Gastroenterology, 2009,136(3):1012-1024.
  • 10Yang W, Wang C, Lin Y, et al. OV6(+) tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma[J]. J Hepatol, 2012,57(3):613-620.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部